Vident Partners provides vetted radiation oncology expert witnesses for cases involving treatment planning and target-volume errors, radiation overdose and misadministration, brachytherapy source placement failures, late radiation toxicity, and NRC-reportable medical events. Request a referral today.
Find a Radiation Oncology Expert →Overview
Radiation oncology experts evaluate whether the prescription, planning, delivery, and follow-up of therapeutic radiation met the standard of care. Board certification in radiation oncology through the American Board of Radiology requires a four-year ACGME-accredited residency that includes 36 months of clinical radiation oncology, and candidates must pass separate qualifying examinations in medical physics for radiation oncology, radiation and cancer biology, and clinical radiation oncology before sitting for an oral certifying examination covering eight clinical categories 1.
Litigation in this field rarely turns on the decision to irradiate. It turns on execution. External beam radiation therapy directs radiation at the tumor from a machine, brachytherapy places sealed sources -- seeds, ribbons, or capsules -- in or near the tumor, and systemic radiopharmaceuticals deliver a liquid source internally 2. Each modality carries its own failure modes: contouring and target-volume errors that produce a geographic miss, immobilization and daily setup errors that displace the delivered dose, prescription and fractionation errors, source migration in permanent implants, and failure to account for prior radiation when re-treating a previously irradiated field.
Radiation oncology is one of the few clinical specialties governed by a mandatory federal error-reporting regime, which frequently supplies the documentary spine of a case. Under 10 CFR 35.3045, a licensee must report a medical event to the Nuclear Regulatory Commission when an administration delivers a dose differing from the prescribed dose by more than 0.05 Sv (5 rem) effective dose equivalent or 0.5 Sv (50 rem) to an organ or tissue, and the total dose delivered differs from the prescription by 20 percent or more, or a single fraction differs from the prescribed fraction by 50 percent or more 3. Wrong-radionuclide, wrong-route, wrong-individual, wrong-treatment-mode, and leaking sealed source events are separately reportable 3. The licensing, authorized-user training, and written-directive requirements that govern medical use of byproduct material appear throughout 10 CFR Part 35 4.
Because the radiation oncologist prescribes but does not personally calibrate the equipment, most cases require paired expertise. The qualified medical physicist is responsible for machine commissioning, output calibration, and periodic quality assurance, and the American Association of Physicists in Medicine publishes the Task Group reports that define those obligations -- including TG-142 on quality assurance of medical accelerators and TG-51 on clinical reference dosimetry of high-energy photon and electron beams 5. Damages analysis usually centers on late toxicity, which can emerge months or years after treatment: radiation necrosis, fistula formation, radiation myelopathy, xerostomia, bowel and bladder injury, and radiation-induced secondary malignancy. Establishing that the toxicity exceeded expected tissue tolerance, rather than representing a known and consented complication of an appropriately delivered course, is the central causation question in most radiation oncology claims.
Under 10 CFR 35.3045, a therapeutic administration must be reported to the Nuclear Regulatory Commission as a medical event when the delivered dose differs from the prescription by more than 5 rem and the total dose differs by 20 percent or more, or a single fraction differs by 50 percent or more.
Case Types
Target-volume delineation and treatment planning errors causing geographic miss
Radiation overdose from dose calculation, calibration, or linear accelerator quality assurance failures
Wrong-site, wrong-patient, and wrong-dose administrations reportable as NRC medical events
Brachytherapy source placement, strength, and migration claims
Failure to diagnose or manage late radiation toxicity including necrosis, fistula, and myelopathy
Informed consent disputes over radiation risk, re-irradiation, and non-radiotherapy alternatives
Qualifications
Related Specialties
FAQ
A radiation oncology expert should be board certified in radiation oncology by the American Board of Radiology, having completed a four-year ACGME-accredited residency including at least 36 months of clinical radiation oncology. Active practice treating the same disease site with the same modality at issue is important, as is familiarity with AAPM quality assurance protocols and NRC medical event reporting requirements.
These experts are retained in cases involving treatment planning and target-volume errors, radiation overdose or underdose, wrong-site or wrong-patient administrations, brachytherapy source placement and migration, failure to recognize and treat late radiation toxicity, and informed consent disputes over radiation risks and alternatives.
Under 10 CFR 35.3045, a licensee must report a medical event to the Nuclear Regulatory Commission when an administration delivers a dose differing from the prescribed dose by more than 5 rem effective dose equivalent or 50 rem to an organ, and the total dose differs from the prescription by 20 percent or more or a single fraction differs by 50 percent or more. Wrong-radionuclide, wrong-route, wrong-patient, and leaking sealed source events are separately reportable. These filings are frequently a key discovery target because they are created contemporaneously with the error.
Frequently, yes. The radiation oncologist prescribes the dose, but a qualified medical physicist is responsible for commissioning, calibration, and periodic quality assurance of the delivery equipment. When the alleged error involves machine output, dose calculation, or quality assurance testing rather than clinical judgment, a physicist expert is usually needed alongside the treating specialty expert.
In general, medical expert fees are determined by the expert themselves, based on a variety of criteria. Among those criteria are clinical experience, forensic experience, academic qualifications such as Fellowships, clinical settings, and publications. Vident does have some influence over expert fees by comparing experts within a specialty, but ultimately it is a personal decision by the expert.
Related Insights
Over the past several years I have reviewed medical charts for both insurance companies and pain clinics to determine if what has been recorded makes good medical sense and shows an appropriate level...
Research BriefingFentanyl, a synthetic opioid, was first developed by Dr. Paul Janssen in the 1960s. From its inception, it was designed to be fast-acting, highly potent, and more readily synthesized than naturally oc...
Case AnalysisI was not familiar with this term before reading Hill v. Emergency Medicine of Idaho and Dr. Stuart Clive (3/27/25). Perhaps the court wasn’t either, because the opinion repeatedly puts “hindsight...
Sources
Vident Partners connects attorneys with qualified radiation oncology expert witnesses. Complimentary consultation, 24-hour turnaround, no obligation.
Request an Expert →